Prevalence of and Risk Factors for Lipoatrophy in Patients with HIV Infection in Nigeria

Prevalence of and Risk Factors for Lipoatrophy in Patients with HIV Infection in Nigeria

Background. Although the association between lipoatrophy and highly active antiretroviral therapy (HAART) is well known, other nondrug factors may be associated with lipoatrophy in people living with HIV/AIDS (PLWHA). There are no reports of lipoatrophy from Nigeria, a country with the second larges...

Full description

Bibliographic Details
Main Authors:	Sandra Omozehio Iwuala, Olufunmilayo A. Lesi, Olufemi Adetola Fasanmade, Anas A. Sabir, Michael Adeyemi Olamoyegun, Charles C. Okany
Format:	Article
Language:	English
Published:	Hindawi Limited 2015-01-01
Series:	AIDS Research and Treatment
Online Access:	http://dx.doi.org/10.1155/2015/402638

Similar Items

Lipoatrophy in HIV-infected children on antiretroviral therapy
by: Innes, Steven Eugene Vere
Published: (2013)

Changes in Peripheral Lipoatrophy, Surrogate Markers of Cardiovascular Disease, and Mitochondria after Rosiglitazone in HIV-infected individuals with Lipoatrophy
by: Tungsiripat, Marisa
Published: (2011)

Effect of Vitamin D supplementation on glycemic control in Type 2 diabetes subjects in Lagos, Nigeria
by: Anthony Chinedu Anyanwu, et al.
Published: (2016-01-01)

Cardiovascular risk factors in semi-urban communities in southwest Nigeria: Patterns and prevalence
by: Rotimi Oluyombo, et al.
Published: (2019-04-01)

Adolescents with HIV and facial lipoatrophy: response to facial stimulation
by: Jesus Claudio Gabana-Silveira, et al.
Published: (2014-08-01)

Cost of surgical intervention for reconstructive therapy of HIV-associated facial lipoatrophy
by: Massella M, et al.
Published: (2011-05-01)

Prospective evidence that HIV lipoatrophy and visceral adiposity are partially independent processes
by: Handan Wand, et al.
Published: (2011-01-01)

Prevalence of a marker of active <it>helicobacter pylori</it> infection among patients with type 2 diabetes mellitus in Lagos, Nigeria
by: Oluyemi Aderemi, et al.
Published: (2012-06-01)

Association between periodontal diseases and systemic illnesses: A survey among internal medicine residents in Nigeria
by: Kehinde A. Umeizudike, et al.
Published: (2016-01-01)

Diabetes Care in Nigeria
by: Olufemi A. Fasanmade, et al.
Published: (2016-04-01)

Prevalence of diabetes mellitus and its risk factors among the suburban population of Northwest Nigeria
by: Anas Ahmad Sabir, et al.
Published: (2017-01-01)

The Value of Magnetic Resonances Imaging in Localized Lipoatrophy
by: Amber EKER, et al.
Published: (2019-07-01)

A Case Of Bilateral Acquired Localized Lipoatrophy
by: Osman Tanrıkulu, et al.
Published: (2016-07-01)

LOCALISED INVOLUTIONAL LIPOATROPHY: A CASE REPORT
by: Sathish Pai, et al.
Published: (2013-07-01)

Lipoatrophy associated with daily growth hormone injections
by: Priya Darshani Chhiba, et al.
Published: (2021-09-01)

An Economic Evaluation of HIV-associated Facial Lipoatrophy Treatments: A Cost-utility Analysis
by: Peyasantiwong, Sirianong
Published: (2009)

An Economic Evaluation of HIV-associated Facial Lipoatrophy Treatments: A Cost-utility Analysis
by: Peyasantiwong, Sirianong
Published: (2009)

Persistence of lipoatrophy after a four-year long interruption of antiretroviral therapy for HIV1 infection: case report
by: Toro Giuseppe, et al.
Published: (2005-10-01)

Economic modeling of the combined effects of HIV-disease, cholesterol and lipoatrophy based on ACTG 5142 trial data
by: Garren Kevin W, et al.
Published: (2011-05-01)

Ube2i deletion in adipocytes causes lipoatrophy in mice
by: Aaron R. Cox, et al.
Published: (2021-06-01)

Surrogate markers and predictors of insulin resistance in Nigeria patients with Type 2 diabetes mellitus: A cross sectional study
by: Ifedayo Adeola Odeniyi, et al.
Published: (2021-01-01)

DISCORDANCE BETWEEN BODY MASS INDEX AND ANTHROPOMETRIC MEASUREMENTS AMONG HIV-1-INFECTED PATIENTS ON ANTIRETROVIRAL THERAPY AND WITH LIPOATROPHY/LIPOHYPERTROPHY SYNDROME
by: Lismeia Raimundo SOARES, et al.
Published: (2015-04-01)

Prevalence of and risk factors for hepatitis B and C viral co-infections in HIV infected children in Lagos, Nigeria.
by: Mary Adetola Lawal, et al.
Published: (2020-01-01)

Otologic and audiologic characteristics of type 2 diabetics in a tertiary health institution in Nigeria
by: Stephen Oluwatosin Adebola, et al.

Concomitant development of morphea and lipoatrophy after local corticosteroid injection
by: Yang Lo, et al.
Published: (2020-01-01)

Idiopathic localized involutional lipoatrophy in a child with spontaneous resolution
by: Reena Kumari Sharma, et al.
Published: (2018-01-01)

Insulin Aspart–Induced Lipoatrophy Treated Successfully With Glucocorticoid Injection
by: Arijit Singha, MD, et al.
Published: (2017-01-01)

High prevalence of lipoatrophy in pre-pubertal South African children on antiretroviral therapy: a cross-sectional study
by: Innes Steve, et al.
Published: (2012-11-01)

Facial biostimulation with PRP activated with ozone resound on cellular redox balance, improves lipoatrophy and quality of life in HIV patients
by: Lizette Gil-del Valle, et al.
Published: (2019-07-01)

Gender inequities in sexually transmitted infections: implications for HIV infection and control in Lagos State, Nigeria
by: Ezekiel Oluwagbemiga Adeyemi
Published: (2011-08-01)

Idiopathic localized involutional lipoatrophy: A retrospective study of 12 cases
by: Reena K Sharma, et al.
Published: (2019-01-01)

The adrenal gland and the patient with pulmonary tuberculosis infected with human immunodeficiency virus
by: Ifedayo Adeola Odeniyi, et al.
Published: (2017-01-01)

Lipoatrofia facial associada ao HIV/AIDS: do advento aosconhecimentos atuais HIV-Associated facial lipoatrophy: from the advent to current knowledge
by: Flávia Machado Gonçalves Soares, et al.
Published: (2011-10-01)

Fiscal Decentralisation and Economic Development in Nigeria: Empirical Evidence from VECM Model
by: Hammed Adetola Adefeso, et al.
Published: (2014-04-01)

Lipoatrophy/lipohypertrophy outcomes after antiretroviral therapy switch in children in the UK/Ireland.
by: Steve Innes, et al.
Published: (2018-01-01)

Lipoatrofia semicircular: ¿otras medidas eficaces? Semicircular lipoatrophy: are there effective alternative measures?
by: Luis Reinoso Barbero, et al.
Published: (2012-08-01)

A Case of Facial Lipoatrophy Secondary to Lupus Profundus Managed with Lipofilling Technique
by: Luigi Valdatta, et al.
Published: (2012-01-01)

Association of hypertension and obesity with HIV and antiretroviral therapy in a rural tertiary health center in Nigeria: a cross-sectional cohort study
by: Ogunmola OJ, et al.
Published: (2014-03-01)

Idiopathic facial lipoatrophy in a healthy middle-aged woman: a case report
by: Chad Purcell, et al.
Published: (2019-11-01)

Insulin-induced Lipoatrophy in a Patient on Insulin Analogue Therapy: a Case Report
by: Vesselina Yanachkova, et al.
Published: (2020-09-01)

Cannot write session to /tmp/vufind_sessions/sess_58vk8jq9knpmi30it4enmtki57